<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03322371</url>
  </required_header>
  <id_info>
    <org_study_id>87693</org_study_id>
    <nct_id>NCT03322371</nct_id>
  </id_info>
  <brief_title>Validation of Frontal EEG to Formal Polysomnography in the ICU</brief_title>
  <official_title>Validation of Frontal Limited Lead Electroencephalography (EEG) to Formal Polysomnography (PSG) in the Intensive Care Unit (ICU)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Epitel, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare a 2-lead frontal electroencephalogram recording to a&#xD;
      formal polysomnography (PSG) in detecting sleep vs. wake and depth of sleep in both healthy&#xD;
      and ICU patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sleep in the intensive care unit (ICU) is poor and not well understood. Formal&#xD;
      polysomnography (PSG) is the gold standard measure, but impractical for critical care. The&#xD;
      relative influence of environment, illness and interventions on sleep in critically ill&#xD;
      patients is therefore essentially unknown. Interventions to improve sleep have been pragmatic&#xD;
      and outcomes subjective or indirect, and uninformed. When it is done, formal PSG in critical&#xD;
      illness demonstrates fragmented, shortened, interrupted and non-circadian sleep, with&#xD;
      environmental noise, light, and frequent physical stimulation causing arousals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty analyzing PSG data&#xD;
  </why_stopped>
  <start_date type="Actual">November 6, 2017</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep Stage Correlation</measure>
    <time_frame>Overnight (with a minimum of 960 epochs)</time_frame>
    <description>The correlation of each sleep stage (Wake, NREM1, NREM2, NREM3, REM) as assessed by polysomnography vs. EEG via analysis of 30-second intervals (epochs)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep vs Wake Correlation</measure>
    <time_frame>Overnight (with a minimum of 960 epochs)</time_frame>
    <description>The correlation of sleep (NREM1, NREM2, NREM3, REM) vs wake as assessed by polysomnography vs. EEG via analysis of 30-second intervals (epochs)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sound and Light during Sleep</measure>
    <time_frame>Overnight (with a minimum of 960 epochs)</time_frame>
    <description>The correlation of sleep stage (Wake, NREM1, NREM2, NREM3, REM) with sound and light levels within the ICU.</description>
  </other_outcome>
  <other_outcome>
    <measure>Environmental Conditions during Sleep</measure>
    <time_frame>Overnight (with a minimum of 960 epochs)</time_frame>
    <description>The correlation of sleep stage (Wake, NREM1, NREM2, NREM3, REM) with environmental conditions within the ICU.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Sleep Deprivation</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Health Subjects in Sleep Lab</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adult patients (&gt; 18yrs old) scheduled for a standard of care PSG (sleep study) lasting at least 8 hours for any condition. Patients will undergo simultaneous 2-lead limited EEG recording with experimental device. 2-lead limited electroencephalography recording</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU patients, not sedated or ventilated</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adult ICU patients (&gt; 18yrs old) anticipated to stay in the ICU overnight (minimum 8 hours) with a Glasgow Coma Scale of 13 or greater, not intubated and not sedated. Patients will undergo simultaneous 2-lead limited electroencephalography recording</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU patients, sedated and ventilated</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adult ICU patients (&gt; 18yrs old) who are intubated, sedated, ventilated, and anticipated to stay in the ICU overnight (minimum 8 hours). Patients will undergo simultaneous 2-lead limited electroencephalography recording</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2-lead limited electroencephalography recording</intervention_name>
    <description>The EEG recording device will be placed in conjunction with the standard formal polysomnography (PSG). The EEG device will remain in place as long as PSG leads are connected to the subject and PSG machine.</description>
    <arm_group_label>Health Subjects in Sleep Lab</arm_group_label>
    <arm_group_label>ICU patients, not sedated or ventilated</arm_group_label>
    <arm_group_label>ICU patients, sedated and ventilated</arm_group_label>
    <other_name>Health Subjects in Sleep Lab</other_name>
    <other_name>ICU patients, not sedated or ventilated</other_name>
    <other_name>ICU patient, sedated and ventilated</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Group 1: Healthy Subjects in Sleep Lab:&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Scheduled for a standard of care polysomnography lasting at least 8 hours for any&#xD;
             condition&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Patient/Legally Authorized Representative declines consent&#xD;
&#xD;
        Group 2: ICU patient, not sedated, not ventilated&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Anticipated to stay in intensive care unit overnight (minimum 8 hours)&#xD;
&#xD;
          -  Glasgow Coma Scale score of 13 or great&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intubated with endotracheal tube&#xD;
&#xD;
          -  Sedated (includes sedative drugs such as propofol, Dexmedetomidine, versed infusion&#xD;
             above 2mg/hr, ketamine infusion above 0.2 mg/kg/hr).&#xD;
&#xD;
        Group 3: ICU patient, sedated and ventilated&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Anticipated to stay in the intensive care unit overnight (minimum 8 hours)&#xD;
&#xD;
          -  Intubated, sedated, and ventilated&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of traumatic brain injury&#xD;
&#xD;
          -  Planned extubation in next 8 hours&#xD;
&#xD;
          -  Scheduled to leave the intensive care unit for any reason in the next 8 hours&#xD;
&#xD;
          -  Anticipated life expectancy of less than 24 hours&#xD;
&#xD;
          -  Electroencephalogram monitoring (current or scheduled in the next 8 hours)&#xD;
&#xD;
          -  Hemodynamic instability (defined as: (i) mean arterial pressure &lt;60mmHg for &gt;20&#xD;
             minutes with efforts to raise it or (ii) &gt;2 liter fluid administered in 2h after&#xD;
             operating room and anticipating on-going needs for fluid resuscitation or (iii) ICU MD&#xD;
             determination of &quot;atypical and profound hemodynamic instability&quot; or (iv) PI&#xD;
             determination after evaluation.&#xD;
&#xD;
          -  Refractory hypoxemia - defined as Saturation &lt;88% on Sp02 despite efforts to increase&#xD;
             it&#xD;
&#xD;
          -  Hemorrhage - defined as &gt;500cc chest tube output in 2h and anticipated need of more&#xD;
             than 2 units of packed red blood cells in immediate post op period. This does NOT&#xD;
             include cell-saver.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Tonna, MD, FAAEM</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 23, 2017</study_first_submitted>
  <study_first_submitted_qc>October 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2017</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Joseph Tonna</investigator_full_name>
    <investigator_title>Associate Director, ECMO Services</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Deprivation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

